Golden Throat Holdings Group Company Limited (HKG:6896)

Market Cap	2.59B
Revenue (ttm)	1.07B
Net Income (ttm)	293.79M
Shares Out	739.30M
EPS (ttm)	0.40
PE Ratio	8.81
Forward PE	n/a
Dividend	0.50 (14.37%)
Ex-Dividend Date	Jun 16, 2025

Volume	1,363,000
Average Volume	2,500,633
Open	3.500
Previous Close	3.480
Day's Range	3.460 - 3.520
52-Week Range	3.000 - 5.650
Beta	0.15
RSI	30.75
Earnings Date	Aug 22, 2025

About HKG:6896

Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People’s Republic of China and internationally. The company offers Golden Throat Lozenges, an over-the-counter medicine to relieve symptoms of sore and dry throat, and hoarse voice caused by acute pharyngitis. It also provides Golden Throat Lozenge series products, which include Dule Lozenges; sugar-free Dule Lozenges; and other sugar free flavours, such as orange, fructus momordicae, chr...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1956
• Employees: 874
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6896

Financial Performance

In 2024, HKG:6896's revenue was 1.19 billion, an increase of 23.26% compared to the previous year's 961.38 million. Earnings were 318.63 million, an increase of 27.37%.

Financial numbers in CNY